First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2014-12-19 10:00:33Open Document File Size: 1,09 MBShare Result on FacebookCityVancouver / Québec / /CompanyFTQ & Zymeworks Inc. / Zymeworks Inc. / /CountryCanada / /CurrencyUSD / / /IndustryTermtreatment of breast and gastric cancers / biotechnology expertise / treatment of cancer / treatment of oncology / autoimmunity and inflammatory diseases / media representatives / biotechnology sectors / protein engineering technology / /MedicalConditionbreast cancers / cancer / gastric cancers / low-HER2 expressing tumours / inflammatory diseases / /OrganizationNational Research Council of Canada / /PersonAli Tehrani / Alain Denis / David Poon / Patrick McQuilken / / /PositionVice-President / Advisor / Media Relations and Communications / President & CEO / Director / External R&D and Alliances Phone / /ProductZymeCAD / /Technologyprotein engineering technology / antibodies / biotechnology / drug development / /URLwww.FondsFTQ.com / www.zymeworks.com / /SocialTag |